Ipsen SA banner

Intrinsic Value

Is I7G undervalued or overvalued?

See the intrinsic value estimate for Ipsen SA and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

I7G Intrinsic Value
LOCKED
Unlock
Today vs. history

I7G looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with I7G’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor I7G
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Current Price €157
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to I7G

Fundamental Analysis

What Ipsen Does

Pharmaceuticals Health Care

Ipsen is a French specialty pharmaceutical company that develops and sells prescription medicines for serious diseases, especially in oncology, rare diseases, and certain neurological conditions. Its business is built around branded drugs that doctors prescribe in hospitals and clinics, rather than over-the-counter products.

Headquarters
France FR
Employees
5 535
IPO date
Dec 6, 2005
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Ipsen SA

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

IPN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one I7G stock?

The intrinsic value for Ipsen SA (I7G) under the Base Case is hidden EUR.

Is I7G stock undervalued or overvalued?

Compared with the current market price of 157 EUR, the stock appears hidden.

Back to Top